How 'The Year of Ozempic' Transformed Obesity Treatment… and Much More
We’ll talk with journalist and physician Dhruv Khullar about his NewYorker piece "The Year of Ozempic" and check in with UCSF weight loss doctor Diana Thiara about what we’ve learned about drugs like Ozempic and Wegovy over the past year.
Audio is streamed directly from the publisher (podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In a recent piece for the New Yorker called “The Year of Ozempic,” journalist and physician Dhruv Khullar writes that “we may look back on new weight-loss drugs as some of the greatest advances in the annals of chronic disease.” But the drugs don’t work for everyone, and there are ongoing questions about side effects, costs and availability. We’ll talk with Khullar about his piece and check in with UCSF weight loss doctor Diana Thiara about what we’ve learned about drugs like Ozempic and Wegovy over the past year.
Learn more about your ad choices. Visit megaphone.fm/adchoices